U.S. FDA Approves Jazz's Combination Therapy for Lung Cancer
The FDA approved the Zepzelca/Tecentriq drug combo as a maintenance treatment for advanced small cell lung cancer.
/ 8 items
The FDA approved the Zepzelca/Tecentriq drug combo as a maintenance treatment for advanced small cell lung cancer.
Amneal Pharmaceuticals receives FDA approval for its generic sodium oxybate, offering a more accessible and cost-effective treatment for narcolepsy's excessive sleepiness and cataplexy in patients 7+.